Louisville, KY (PRWEB) July 13, 2011
Patient monitors such as the DRE Waveline Touch can help medical providers follow new standards from the American Society of Anesthesiologists.
The ASA’s new guidelines, which went into effect July 1, call for the monitoring of exhaled carbon dioxide in lower levels of sedation than was previously required. Now, the ASA requires CO2 monitoring for deep and moderate sedation.
Previously, the ASA called for monitoring during general anesthesia, the deepest level of sedation. The revised section is Standard 3.2.4 in the VENTILATION, METHODS section:
"During regional anesthesia (with no sedation) or local anesthesia (with no sedation), the adequacy of ventilation shall be evaluated by continual observation of qualitative clinical signs. During moderate or deep sedation the adequacy of ventilation shall be evaluated by continual observation of qualitative clinical signs and monitoring for the presence of exhaled carbon dioxide unless precluded or invalidated by the nature of the patient, procedure, or equipment."
Patient monitors such as the FDA-approved DRE Waveline Touch have sensors to measure exhaled CO2 to ensure proper ventilation. The touchscreen DRE Waveline Touch also measures ECG, respiration, SPO2, NIBP and temperature, and with optional dual invasive blood pressure and EtCO2 monitoring.
About DRE Medical Equipment:
DRE is a premier medical and operating room equipment supplier that provides a combination of new and professionally refurbished or used medical equipment to industry professionals around the globe. DRE offers value to doctors by providing the features and reliability they need while still fitting within their budget. This release is for informational purposes only. DRE is not affiliated with the ASA and is not responsible for any changes to the standards or for any issues with their implementation.